Meaningful Use Certification  
 
CERTIFICATION STATEMENT

"Meaningful-Use Certified UniCharts EMR version 4.0" by UnisonCare Corporation completed EHR certification on 12/18/2014 for the following:

Complete EHR Ambulatory

Clinical Quality Measures tested: 2v3; 50v2; 68v3; 69v2; 75v2; 90v3; 117v2; 122v2; 123v2; 124v2; 125v2; 126v2; 127v2; 128v2; 129v3; 130v2; 131v2; 134v2; 135v2; 136v3; 137v2; 138v2; 140v2; 141v3; 142v2; 143v2; 144v2; 145v2; 146v2; 147v2; 153v2; 154v2; 155v2; 156v2; 163v2; 164v2; 165v2; 166v3; 167v2; 182v3
Additional software used: Microsoft HealthVault, Sendinc, Outlook or Thunderbird

This Complete EHR certification holds Certificate No. 12182014-2604-3 and has been certified by Drummond Group Inc., an ONC-ATCB, authorized to conduct complete and modular EHR testing and certification in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.




The "Meaningful-Use Certified UniCharts EMR version 4.0" is certified for all of the core and menu-set elective requirements, making it 100% certified for Stage 1 and Stage 2 Meaningful Use (with e-prescription through free nationalerx.com or any user preferred web-based service). Furthermore, UniCharts electronic medical records system in question has been certified to include 40 Clinical Quality Measures, enabling eligible physicians and providers select the ones that best suit their specialty and workflow needs: These 40 measures are:

ADULT RECOMMENDED MEASURES:
  1. CMS165v2 (NQF 0018) - Controlling High Blood Pressure  [Domain: Clinical Process/Effectiveness]
  2. CMS156v2 (NQF 0022) - Use of High-Risk Medications in the Elderly  [Domain: Patient Safety]
  3. CMS138v2 (NQF 0028) - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention  [Domain: Population/Public Health]
  4. CMS166v3 (NQF 0052) - Low Back Pain: Use of Imaging Studies  [Domain: Efficient Use of Healthcare Resources]
  5. CMS068v3 (NQF 0419) - Documentation of Current Medications in the Medical Record  [Domain: Patient Safety]
  6. CMS069v2 (NQF 0421) - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up  [Domain: Population/Public Health]
  7. CMS050v2 (TBD 0000) - Closing the referral loop: Receipt of specialist report  [Domain: Care Coordination]
  8. CMS090v3 (TBD 0000) - Functional Status Assessment for complex chronic conditions  [Domain: Patient and Family Engagement]
  9. CMS002v3 (NQF 0418) - Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan  [Domain: Population/Public Health]
PEDIATRIC RECOMMENDED MEASURES:
  1. CMS146v2 (NQF 0002) - Appropriate Testing for Children with Pharyngitis  [Domain: Efficient Use of Healthcare Resources]
  2. CMS155v2 (NQF 0024) - Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents  [Domain: Population/Public Health]
  3. CMS153v2 (NQF 0033) - Chlamydia Screening for Women  [Domain: Population/Public Health]
  4. CMS126v2 (NQF 0036) - Use of Appropriate Medications for Asthma  [Domain: Clinical Process/Effectiveness]
  5. CMS117v2 (NQF 0038) - Childhood Immunization Status  [Domain: Population/Public Health]
  6. CMS154v2 (NQF 0069) - Appropriate Treatment for Children with Upper Respiratory Infection (URI)  [Domain: Efficient Use of Healthcare Resources]
  7. CMS136v3 (NQF 0108) - ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication  [Domain: Clinical Process/Effectiveness]
  8. CMS075v2 (TBD 0000) - Children who have Dental Decay or Cavities  [Domain: Clinical Process/Effectiveness]
  9. CMS002v3 (NQF 0418) - Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan  [Domain: Population/Public Health]
ADDITIONAL MEASURES:
  1. CMS147v2 (NQF 0041) - Preventive Care and Screening: Influenza Immunization  [Domain: Population/Public Health]
  2. CMS137v2 (NQF 0004) - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement  [Domain: Clinical Process/Effectiveness]
  3. CMS125v2 (NQF 0031) - Breast Cancer Screening  [Domain: Clinical Process/Effectiveness]
  4. CMS124v2 (NQF 0032) - Cervical Cancer Screening  [Domain: Clinical Process/Effectiveness]
  5. CMS130v2 (NQF 0034) - Colorectal Cancer Screening  [Domain: Clinical Process/Effectiveness]
  6. CMS127v2 (NQF 0043) - Pneumonia Vaccination Status for Older Adults  [Domain: Clinical Process/Effectiveness]
  7. CMS131v2 (NQF 0055) - Diabetes: Eye Exam  [Domain: Clinical Process/Effectiveness]
  8. CMS123v2 (NQF 0056) - Diabetes: Foot Exam  [Domain: Clinical Process/Effectiveness]
  9. CMS122v2 (NQF 0059) - Diabetes: Hemoglobin A1c Poor Control  [Domain: Clinical Process/Effectiveness]
  10. CMS134v2 (NQF 0062) - Diabetes: Urine Protein Screening  [Domain: Clinical Process/Effectiveness]
  11. CMS163v2 (NQF 0064) - Diabetes: Low Density Lipoprotein (LDL) Management and Control  [Domain: Clinical Process/Effectiveness]
  12. CMS164v2 (NQF 0068) - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic  [Domain: Clinical Process/Effectiveness]
  13. CMS145v2 (NQF 0070) - Coronary Artery Disease (CAD): Beta-Blocker Therapy: Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)  [Domain: Clinical Process/Effectiveness]
  14. CMS182v3 (NQF 0075) - Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control  [Domain: Clinical Process/Effectiveness]
  15. CMS135v2 (NQF 0081) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)  [Domain: Clinical Process/Effectiveness]
  16. CMS144v2 (NQF 0083) - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)  [Domain: Clinical Process/Effectiveness]
  17. CMS143v2 (NQF 0086) - Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation  [Domain: Clinical Process/Effectiveness]
  18. CMS167v2 (NQF 0088) - Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy  [Domain: Clinical Process/Effectiveness]
  19. CMS142v2 (NQF 0089) - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care  [Domain: Clinical Process/Effectiveness]
  20. CMS128v2 (NQF 0105) - Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b) Effective Continuation Phase Treatment  [Domain: Clinical Process/Effectiveness]
  21. CMS141v3 (NQF 0385) - Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients  [Domain: Clinical Process/Effectiveness]
  22. CMS140v2 (NQF 0387) - Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer  [Domain: Clinical Process/Effectiveness]
  23. CMS129v3 (NQF 0389) - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients  [Domain: Efficient Use of Healthcare Resources]

Disclosure/Transparency Statement:

A license key for certified UniCharts EMR version 4.0 is a one-time expense as the key never expires, whereas the annual support fee is about 20% cost of the license key and is optional. However, if needed by the customer, this certified product may require additional one-time cost to establish interfaces for reporting to immunization registries and public health agencies (170.314.f.2 and 170.314.f.3). Similarly, the support for integration of UniCharts EMR version 4.0 with other ONC certified systems may require additional one-time costs.


UnisonCare Corporation 2003 - 2016. All Rights Reserved.